SCHEMBL5116056

SCHEMBL5116056

CC(C)C(=O)Nc1cc(Cl)cc(COc2c(Cl)cc(CC(F)C(=O)O)cc2Cl)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 2/20 0.38
FFAR1 O14842 2/20 0.38
SENP5 Q96HI0 1/20 0.38
SENP2 Q9HC62 1/20 0.38
SENP1 Q9P0U3 1/20 0.38
THRA P10827 1/20 0.37
THRB P10828 1/20 0.37
KMT2A Q03164 4/20 0.36
MEN1 O00255 3/20 0.36
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
ALDH1A1 P00352 4/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MRGPRX4 Q96LA9 1/20 0.34
MAPT P10636 1/20 0.34
SLC16A3 O15427 1/20 0.34
SLC16A1 P53985 1/20 0.34
MCTS1 Q9ULC4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5104161 0.91 KMT2A (0.39) PTGER1FFAR1SENP5SENP2SENP1
SCHEMBL5118803 0.91 THRA (0.39) PTGER1FFAR1SENP5SENP2SENP1
SCHEMBL5112370 0.89 FFAR1 (0.39) PTGER1FFAR1SENP5SENP2SENP1
SCHEMBL5112585 0.88 MME (0.41) PTGER1SENP5SENP2SENP1THRA
SCHEMBL5119830 0.87 TSHR (0.40) PTGER1FFAR1SENP5SENP2SENP1
SCHEMBL4926575 0.87 FFAR1 (0.39) FFAR1THRBKMT2AMEN1LMNA
SCHEMBL4933397 0.87 FFAR1 (0.40) FFAR1THRATHRBKMT2AMEN1
SCHEMBL5722495 0.86 THRA (0.37) PTGER1FFAR1SENP5SENP2SENP1
SCHEMBL5722513 0.85 THRA (0.35) PTGER1FFAR1THRATHRBLMNA
SCHEMBL4922903 0.85 FFAR1 (0.39) FFAR1THRATHRBKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor KARO BIO AB (SE) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor TSHR, TRHR, THRA PTGER1 138/4885FFAR1 34/4885SENP5 2379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.